Xi Chen Lin

Xi Chen Lin

Chief Tech/Sci/R&D Officer at STRUCTURE THERAPEUTICS INC.

Net worth: 4 M $ as of 30/07/2026

52 year
Health Technology
Consumer Services

Profile

Dr. Xi Chen Lin is a Chief Scientific Officer & GM-Structure Shanghai at Structure Therapeutics, Inc. and a General Manager at Shanghai ShouTi Biotechnology Co. Ltd. Dr. Lin was previously employed as a Head-Asia Pacific External Innovation by Novo Nordisk A/S.
He received his undergraduate degree from Peking University and a doctorate degree from The Pennsylvania State University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
17/08/2026 228,960 ( 0.16% ) 4 M $ 30/07/2026

Xi Chen Lin active positions

CompaniesPositionStart
STRUCTURE THERAPEUTICS INC. Chief Tech/Sci/R&D Officer 30/06/2019
Chief Executive Officer -

Former positions of Xi Chen Lin

CompaniesPositionEnd
NOVO NORDISK A/S Corporate Officer/Principal 30/06/2019
See the detail of Xi Chen Lin's experience

Training of Xi Chen Lin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

45

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies5

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology